Targeting melanoma's MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors.

Sale MJ, Minihane E, Monks NR, Gilley R, Richards FM, Schifferli KP, Andersen CL, Davies EJ, Vicente MA, Ozono E, Markovets A, Dry JR, Drew L, Flemington V, Proia T, Jodrell DI, Smith PD, Cook SJ
Nat Commun. 2019 Nov 14;10(1):5167. doi: 10.1038/s41467-019-12409-w. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.